The Role of Dr. Keith Meister in the Texas Rangers’ Success

The Texas Rangers have a standout figure in the medical field, Dr. Keith Meister, who is considered an MVP for his expertise in Tommy John surgery. As one of the leading surgeons specializing in this procedure, Meister has made significant contributions to the field by pioneering a “hybrid” technique. This method combines traditional reconstruction of a torn ulnar collateral ligament (UCL) with a synthetic internal brace suture, according to reports from the Dallas Morning News.

One of the most recent pitchers to undergo this surgery was Jacob deGrom, a starter for the Rangers. He had the procedure in 2023 and returned to full-time play last season, earning an All-Star Game berth and being named the American League Comeback Player of the Year. His success highlights the effectiveness of Meister’s approach.

Dr. Meister is not only a valuable resource for the Rangers but also for all 30 teams in Major League Baseball. While the Rangers prefer to use him less frequently, other teams often send their pitchers to him for the surgery. His work has become an essential part of the baseball landscape.

Tommy John Surgeries in the 2025 Season

Baseball writer and analyst Jon Roegele recently examined every MLB pitching staff in 2025 to determine how many pitchers had undergone Tommy John surgery at some point in their careers. His findings were surprising. Last season, 39.1% of all Major League pitchers had the surgery, which can occur at any stage of a player’s career, from youth baseball to the Majors.

While the Texas Rangers did not lead the league in the number of pitchers who had the procedure, they still had several players on their roster who had undergone it. These included Danny Coulombe, Patrick Corbin, Jacob Webb, Nathan Eovaldi, Dane Dunning, Codi Heuer, Luke Jackson, Tyler Mahle, Kumar Rocker, Jacob deGrom, and Jose Corniell. Notably, deGrom and Eovaldi had the surgery twice each—deGrom during his minor league years with the Mets and Eovaldi while in high school in Alvin, Texas. Corniell and Rocker had their surgeries as prospects, with Dr. Meister performing both procedures.

Despite the prevalence of Tommy John surgeries, the Rangers’ performance last season was not hindered. Their starting staff recorded one of the best ERAs in baseball, and Eovaldi could have won the American League ERA title if he had the necessary innings to qualify. DeGrom, Eovaldi, and Jack Leiter—who has not had the procedure—each achieved 10 or more wins.

At one point, the Rangers had four out of five pitchers in their rotation who had undergone the surgery, showcasing the widespread impact of the procedure across the team.

Strong Performance from the Bullpen

The Rangers’ bullpen also contributed significantly to their overall success. With a 3.62 ERA, it ranked fifth in baseball. Combined with the strong performance of the rotation, the team’s overall ERA of 3.47 was the best in the Majors. Pitchers like Coulombe, Webb, and Jackson played key roles in maintaining this impressive statistic.

Teams generally hope their pitchers can avoid the need for Tommy John surgery. However, the results from the 2025 season show that the injury no longer poses a significant hindrance to a pitcher’s longevity. The Rangers’ success demonstrates that even with multiple players having undergone the procedure, the team can still perform at a high level.

Key Players and Future Outlook

Several players on the Rangers’ roster have shown promise and potential for future success. Yolfran Castillo is emerging as a rising star in the organization’s international talent pipeline. The team’s New Year’s resolution hinges on its young core stepping up in the upcoming season. The final return on the Joey Gallo trade is still waiting for the right opportunity in MLB.

A bold prediction suggests that Wyatt Langford could deliver a monster season for the Rangers. These developments highlight the ongoing growth and evolution of the team as they continue to build on their recent successes.